Stockscreener 앱 받기
72.88
1.05%
-0.77
시간 외 거래:
72.88
전일 마감가:
$73.65
열려 있는:
$72.4
하루 거래량:
1.73M
Relative Volume:
0.70
시가총액:
$11.62B
수익:
$705.14M
순이익/손실:
$-453.90M
주가수익비율:
-23.97
EPS:
-3.04
순현금흐름:
$-551.29M
1주 성능:
-0.94%
1개월 성능:
+5.39%
6개월 성능:
+122.33%
1년 성능:
+89.59%
1일 변동 폭
$72.40
$74.21
1주일 범위
$71.14
$75.49
52주 변동 폭
$23.95
$75.49
Ionis Pharmaceuticals Inc Stock (IONS) Company Profile
명칭
Ionis Pharmaceuticals Inc
전화
(760) 931-9200
주소
2855 GAZELLE COURT, CARLSBAD, CA
IONS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IONS
Ionis Pharmaceuticals Inc
|
72.88 | 11.93B | 705.14M | -453.90M | -551.29M | -3.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ionis Pharmaceuticals Inc Stock (IONS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-08 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-09-26 | 업그레이드 | Goldman | Sell → Neutral |
| 2025-09-03 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2025-07-31 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-04-07 | 개시 | H.C. Wainwright | Buy |
| 2025-03-31 | 개시 | Redburn Atlantic | Neutral |
| 2024-08-02 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2024-07-24 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-07-16 | 재개 | Jefferies | Buy |
| 2024-06-14 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2024-04-10 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2024-01-02 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-10-23 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-09-29 | 개시 | Raymond James | Strong Buy |
| 2023-07-31 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-06-07 | 재개 | Piper Sandler | Overweight |
| 2023-05-04 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-03-21 | 개시 | Bernstein | Underperform |
| 2022-12-21 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-09-09 | 재개 | Morgan Stanley | Overweight |
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
| 2022-03-31 | 재개 | Piper Sandler | Overweight |
| 2022-03-01 | 개시 | Citigroup | Sell |
| 2022-03-01 | 개시 | Guggenheim | Buy |
| 2022-02-01 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2021-12-14 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2021-05-07 | 업그레이드 | UBS | Sell → Neutral |
| 2021-03-01 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2020-12-16 | 개시 | UBS | Sell |
| 2020-12-15 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2020-09-14 | 재개 | JP Morgan | Neutral |
| 2020-09-02 | 개시 | The Benchmark Company | Hold |
| 2020-06-01 | 재개 | Oppenheimer | Outperform |
| 2020-05-13 | 개시 | RBC Capital Mkts | Outperform |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-12-13 | 개시 | Oppenheimer | Outperform |
| 2019-11-13 | 개시 | BofA/Merrill | Buy |
| 2019-11-07 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2019-09-10 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2018-08-08 | 재확인 | Stifel | Hold |
| 2018-08-07 | 재확인 | Stifel | Hold |
| 2018-05-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2017-10-06 | 재개 | Goldman | Sell |
| 2017-08-17 | 개시 | Evercore ISI | Outperform |
| 2017-08-09 | 재확인 | Stifel | Hold |
| 2017-03-10 | 다운그레이드 | Goldman | Neutral → Sell |
| 2016-12-28 | 재확인 | BMO Capital Markets | Outperform |
| 2016-12-27 | 재확인 | Leerink Partners | Mkt Perform |
모두보기
Ionis Pharmaceuticals Inc 주식(IONS)의 최신 뉴스
Ionis: What Upside Is Left After Shares Rocketed Higher Following Positive Trial Data? - Seeking Alpha
Ionis Pharmaceuticals (IONS) Sees Analyst Target Price Increase - GuruFocus
Corton Capital Inc. Invests $570,000 in Ionis Pharmaceuticals, Inc. $IONS - MarketBeat
How Ionis Pharmaceuticals Inc. (ISI) stock compares with tech leadersMarket Sentiment Summary & Daily Price Action Insights - newser.com
Price momentum metrics for Ionis Pharmaceuticals Inc. explained2025 Valuation Update & Long Hold Capital Preservation Tips - newser.com
Candlestick signals on Ionis Pharmaceuticals Inc. stock todayEarnings Performance Report & Real-Time Chart Breakout Alerts - newser.com
How Ionis Pharmaceuticals Inc. stock trades during market volatilityCEO Change & Consistent Growth Equity Picks - newser.com
What is the fair value estimate for Ionis Pharmaceuticals Inc. (ISI) stock in 2025Chart Signals & Reliable Entry Point Alerts - newser.com
Why Ionis Pharmaceuticals Inc. stock attracts high net worth investorsForecast Cut & Safe Capital Allocation Plans - newser.com
Why ETFs are accumulating Ionis Pharmaceuticals Inc. (ISI) stockPortfolio Risk Report & Entry Point Confirmation Alerts - newser.com
Is Ionis Pharmaceuticals Inc. stock ready for breakoutJuly 2025 Short Interest & AI Powered Buy and Sell Recommendations - newser.com
Insider Sell: Richard Geary Sells 90,929 Shares of Ionis Pharmaceuticals Inc (IONS) - GuruFocus
Why Ionis Pharmaceuticals Inc. stock remains on watchlistsWeekly Risk Summary & Fast Exit/Entry Strategy Plans - newser.com
Ionis Pharma director Loscalzo sells $1.2m in shares By Investing.com - Investing.com Philippines
Ionis Pharmaceuticals EVP Geary sells $6.8m in IONS stock By Investing.com - Investing.com Philippines
Ionis Pharmaceuticals director Wender sells $2m in IONS stock By Investing.com - Investing.com Australia
Ionis Pharmaceuticals EVP Geary sells $6.8m in IONS stock - Investing.com
Ionis Pharma director Loscalzo sells $1.2m in shares - Investing.com
Published on: 2025-11-03 08:52:47 - newser.com
Is Ionis Pharmaceuticals Inc. (ISI) stock attractive post correctionMarket Growth Summary & Weekly Setup with High ROI Potential - newser.com
Is Ionis Pharmaceuticals Inc. (ISI) stock undervalued after correctionProfit Target & Fast Moving Trade Plans - newser.com
Volatility clustering patterns for Ionis Pharmaceuticals Inc.July 2025 Outlook & Precise Trade Entry Recommendations - newser.com
37,649 Shares in Ionis Pharmaceuticals, Inc. $IONS Bought by Y Intercept Hong Kong Ltd - MarketBeat
Will Ionis Pharmaceuticals Inc. (ISI) stock profit from AI boomPortfolio Risk Summary & Growth Focused Entry Point Reports - newser.com
Is Ionis Pharmaceuticals Inc. (ISI) stock a fit for income portfoliosMarket Sentiment Review & Free Safe Entry Trade Signal Reports - newser.com
Is Ionis Pharmaceuticals Inc. stock poised for growth2025 Market Overview & Weekly Market Pulse Updates - newser.com
Wall Street Zen Downgrades Ionis Pharmaceuticals (NASDAQ:IONS) to Hold - MarketBeat
Can Ionis Pharmaceuticals Inc. stock hit analyst price targetsWeekly Gains Summary & Technical Analysis for Trade Confirmation - newser.com
Earnings Update: Here's Why Analysts Just Lifted Their Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Price Target To US$81.91 - simplywall.st
US$81.91That's What Analysts Think Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Is Worth After These Results - Yahoo Finance
Pinnacle Associates Ltd. Sells 113,978 Shares of Ionis Pharmaceuticals, Inc. $IONS - MarketBeat
Can Ionis Pharmaceuticals Inc. stock resist market sell offsWeekly Trade Review & Capital Efficiency Focused Strategies - newser.com
Published on: 2025-10-31 22:00:20 - newser.com
Ionis Pharmaceuticals (NASDAQ:IONS) Price Target Raised to $99.00 - MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) Sets New 1-Year High on Earnings Beat - MarketBeat
Royal Bank Of Canada Issues Positive Forecast for Ionis Pharmaceuticals (NASDAQ:IONS) Stock Price - MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) Given Strong-Buy Rating at Raymond James Financial - MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) Price Target Raised to $90.00 at Needham & Company LLC - MarketBeat
Ionis Pharmaceuticals Inc (IONS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):